A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With GlioblastomaGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 58